Ventas (VTR) Competitors

Ventas logo
$88.82 -0.10 (-0.12%)
Closing price 11/16/2026 03:59 PM Eastern
Extended Trading
$88.90 +0.09 (+0.10%)
As of 11/16/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VTR vs. REG, SBRA, AHR, CTRE, and LTC

Should you buy Ventas stock or one of its competitors? Ventas's main competitors and comparable companies include Regency Centers (REG), Sabra Healthcare REIT (SBRA), American Healthcare REIT (AHR), CareTrust REIT (CTRE), and LTC Properties (LTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "real estate" sector.

How does Ventas compare to Regency Centers?

Ventas (NYSE:VTR) and Regency Centers (NASDAQ:REG) are both large-cap real estate companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

94.2% of Ventas shares are held by institutional investors. Comparatively, 96.1% of Regency Centers shares are held by institutional investors. 0.5% of Ventas shares are held by company insiders. Comparatively, 1.0% of Regency Centers shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Ventas currently has a consensus target price of $99.82, suggesting a potential upside of 12.39%. Regency Centers has a consensus target price of $83.26, suggesting a potential upside of 8.73%. Given Ventas' stronger consensus rating and higher possible upside, analysts clearly believe Ventas is more favorable than Regency Centers.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81
Regency Centers
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

Ventas has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Regency Centers has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Regency Centers has lower revenue, but higher earnings than Ventas. Regency Centers is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventas$5.83B8.05$251.38M$0.53167.58
Regency Centers$1.55B9.03$527.46M$2.7927.45

Regency Centers has a net margin of 31.85% compared to Ventas' net margin of 3.86%. Regency Centers' return on equity of 8.18% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Ventas3.86% 1.86% 0.91%
Regency Centers 31.85%8.18%4.34%

Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. Regency Centers pays an annual dividend of $3.02 per share and has a dividend yield of 3.9%. Ventas pays out 392.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Regency Centers pays out 108.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has increased its dividend for 1 consecutive years and Regency Centers has increased its dividend for 5 consecutive years. Regency Centers is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Ventas had 1 more articles in the media than Regency Centers. MarketBeat recorded 14 mentions for Ventas and 13 mentions for Regency Centers. Ventas' average media sentiment score of 0.69 beat Regency Centers' score of 0.30 indicating that Ventas is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ventas
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Regency Centers
1 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Regency Centers beats Ventas on 14 of the 20 factors compared between the two stocks.

How does Ventas compare to Sabra Healthcare REIT?

Sabra Healthcare REIT (NASDAQ:SBRA) and Ventas (NYSE:VTR) are both real estate companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.9%. Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. Sabra Healthcare REIT pays out 428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas pays out 392.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has raised its dividend for 1 consecutive years.

Sabra Healthcare REIT presently has a consensus price target of $21.92, indicating a potential upside of 7.70%. Ventas has a consensus price target of $99.82, indicating a potential upside of 12.39%. Given Ventas' stronger consensus rating and higher possible upside, analysts clearly believe Ventas is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.60
Ventas
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81

99.4% of Sabra Healthcare REIT shares are held by institutional investors. Comparatively, 94.2% of Ventas shares are held by institutional investors. 1.1% of Sabra Healthcare REIT shares are held by company insiders. Comparatively, 0.5% of Ventas shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sabra Healthcare REIT has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Ventas has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

In the previous week, Ventas had 1 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 14 mentions for Ventas and 13 mentions for Sabra Healthcare REIT. Ventas' average media sentiment score of 0.69 beat Sabra Healthcare REIT's score of 0.56 indicating that Ventas is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ventas
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Sabra Healthcare REIT has a net margin of 7.78% compared to Ventas' net margin of 3.86%. Sabra Healthcare REIT's return on equity of 2.55% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT7.78% 2.55% 1.30%
Ventas 3.86%1.86%0.91%

Ventas has higher revenue and earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.88$155.61M$0.2872.68
Ventas$5.83B8.05$251.38M$0.53167.58

Summary

Ventas beats Sabra Healthcare REIT on 12 of the 20 factors compared between the two stocks.

How does Ventas compare to American Healthcare REIT?

Ventas (NYSE:VTR) and American Healthcare REIT (NYSE:AHR) are both large-cap real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

94.2% of Ventas shares are owned by institutional investors. Comparatively, 16.7% of American Healthcare REIT shares are owned by institutional investors. 0.5% of Ventas shares are owned by insiders. Comparatively, 0.8% of American Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ventas presently has a consensus target price of $99.82, suggesting a potential upside of 12.39%. American Healthcare REIT has a consensus target price of $64.00, suggesting a potential upside of 10.30%. Given Ventas' higher possible upside, analysts plainly believe Ventas is more favorable than American Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81
American Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
3.13

Ventas has higher revenue and earnings than American Healthcare REIT. American Healthcare REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventas$5.83B8.05$251.38M$0.53167.58
American Healthcare REIT$2.26B5.96$69.81M$0.49118.41

In the previous week, Ventas had 4 more articles in the media than American Healthcare REIT. MarketBeat recorded 14 mentions for Ventas and 10 mentions for American Healthcare REIT. Ventas' average media sentiment score of 0.69 beat American Healthcare REIT's score of 0.60 indicating that Ventas is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ventas
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
American Healthcare REIT
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ventas has a net margin of 3.86% compared to American Healthcare REIT's net margin of 3.61%. American Healthcare REIT's return on equity of 2.38% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Ventas3.86% 1.86% 0.91%
American Healthcare REIT 3.61%2.38%1.58%

Ventas has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, American Healthcare REIT has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. American Healthcare REIT pays an annual dividend of $1.00 per share and has a dividend yield of 1.7%. Ventas pays out 392.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. American Healthcare REIT pays out 204.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has raised its dividend for 1 consecutive years. Ventas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Ventas beats American Healthcare REIT on 12 of the 20 factors compared between the two stocks.

How does Ventas compare to CareTrust REIT?

CareTrust REIT (NYSE:CTRE) and Ventas (NYSE:VTR) are both real estate companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

CareTrust REIT has a net margin of 59.18% compared to Ventas' net margin of 3.86%. CareTrust REIT's return on equity of 8.08% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
CareTrust REIT59.18% 8.08% 6.06%
Ventas 3.86%1.86%0.91%

CareTrust REIT currently has a consensus price target of $43.50, indicating a potential upside of 16.32%. Ventas has a consensus price target of $99.82, indicating a potential upside of 12.39%. Given CareTrust REIT's higher probable upside, research analysts clearly believe CareTrust REIT is more favorable than Ventas.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareTrust REIT
0 Sell rating(s)
4 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.73
Ventas
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81

CareTrust REIT has higher earnings, but lower revenue than Ventas. CareTrust REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareTrust REIT$476.39M20.23$320.54M$1.5923.52
Ventas$5.83B8.05$251.38M$0.53167.58

87.8% of CareTrust REIT shares are owned by institutional investors. Comparatively, 94.2% of Ventas shares are owned by institutional investors. 0.7% of CareTrust REIT shares are owned by insiders. Comparatively, 0.5% of Ventas shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CareTrust REIT has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Ventas has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

In the previous week, CareTrust REIT had 21 more articles in the media than Ventas. MarketBeat recorded 35 mentions for CareTrust REIT and 14 mentions for Ventas. Ventas' average media sentiment score of 0.69 beat CareTrust REIT's score of 0.60 indicating that Ventas is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareTrust REIT
5 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Ventas
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.2%. Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. CareTrust REIT pays out 98.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas pays out 392.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT has increased its dividend for 3 consecutive years and Ventas has increased its dividend for 1 consecutive years. CareTrust REIT is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

CareTrust REIT beats Ventas on 12 of the 18 factors compared between the two stocks.

How does Ventas compare to LTC Properties?

Ventas (NYSE:VTR) and LTC Properties (NYSE:LTC) are both real estate companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. LTC Properties pays an annual dividend of $2.28 per share and has a dividend yield of 5.3%. Ventas pays out 392.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. LTC Properties pays out 23.9% of its earnings in the form of a dividend. Ventas has raised its dividend for 1 consecutive years. LTC Properties is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Ventas had 7 more articles in the media than LTC Properties. MarketBeat recorded 14 mentions for Ventas and 7 mentions for LTC Properties. Ventas' average media sentiment score of 0.69 beat LTC Properties' score of 0.54 indicating that Ventas is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ventas
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
LTC Properties
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ventas presently has a consensus target price of $99.82, indicating a potential upside of 12.39%. LTC Properties has a consensus target price of $47.60, indicating a potential upside of 11.26%. Given Ventas' stronger consensus rating and higher probable upside, research analysts clearly believe Ventas is more favorable than LTC Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81
LTC Properties
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.75

94.2% of Ventas shares are owned by institutional investors. Comparatively, 69.3% of LTC Properties shares are owned by institutional investors. 0.5% of Ventas shares are owned by insiders. Comparatively, 2.2% of LTC Properties shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ventas has higher revenue and earnings than LTC Properties. LTC Properties is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventas$5.83B8.05$251.38M$0.53167.58
LTC Properties$262.85M9.15$117.97M$9.544.48

Ventas has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, LTC Properties has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market.

LTC Properties has a net margin of 127.38% compared to Ventas' net margin of 3.86%. LTC Properties' return on equity of 37.19% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Ventas3.86% 1.86% 0.91%
LTC Properties 127.38%37.19%22.06%

Summary

Ventas beats LTC Properties on 11 of the 20 factors compared between the two stocks.

Get Ventas News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VTR vs. The Competition

MetricVentasHealthcare REITs IndustryReal Estate SectorNYSE Exchange
Market Cap$47.41B$13.02B$5.49B$23.48B
Dividend Yield2.32%6.19%5.85%3.79%
P/E Ratio23.6518.9122.0224.87
Price / Sales8.056.514.953.24
Price / Cash25.9421.5625.8915.51
Price / Book2.961.661.753.66
Net Income$251.38M-$1.49M-$72.98M$1.08B
7 Day Performance-1.63%-2.56%-0.58%-2.50%
1 Month Performance3.58%-0.75%0.23%-1.20%
1 Year Performance12.43%9.28%-3.89%7.34%

Ventas Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VTR
Ventas
3.5192 of 5 stars
$88.82
-0.1%
$99.82
+12.4%
+13.9%$47.41B$5.83B23.65542
REG
Regency Centers
2.8165 of 5 stars
$76.11
+1.7%
$83.00
+9.1%
+10.0%$14.07B$1.55B27.28507
SBRA
Sabra Healthcare REIT
2.6176 of 5 stars
$21.47
+2.1%
$21.50
+0.1%
+9.1%$5.52B$774.63M76.6858
AHR
American Healthcare REIT
3.1122 of 5 stars
$58.97
+1.8%
$62.00
+5.1%
+19.9%$12.29B$2.26B29.06121
CTRE
CareTrust REIT
4.6549 of 5 stars
$38.81
+1.6%
$43.64
+12.5%
+4.2%$8.97B$476.39M19.8743

Related Companies and Tools


This page (NYSE:VTR) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners